Site icon Peter A. Hovis

A familiar viral enemy is back with a vengeance

RJ Hamster

A FUNGAL PANDEMIC MAY BE COMING VIEW ONLINE
YOUR WEEKLY CHECKUP
This week: An old respiratory virus is filling children’s hospitals, but hope may be in the wings; the WHO issues a critical new warning about dangerous fungi; the many ways COVID-19 can affect your menstrual cycle.
PHOTOGRAPH BY NIAID
RSV is surging among kids—but scientists have a plan to stop it
Beds in children’s hospitals across the U.S. are filling up with young patients struggling to breath and in dire need of oxygen. The culprit: respiratory syncytial virus, a pathogen that is a leading cause of childhood death worldwide. But new antibody treatments and vaccine candidates may offer long-awaited relief.
WHAT YOU NEED TO KNOW
IN THE NEWS: A ‘tripledemic’? Flu, RSV and COVID may collide this winter, experts say (New York Times) +
JUERGEN BERGER/SCIENCE PHOTO LIBRARY
Humans are not prepared for a pandemic caused by fungal infections
Only about 120,000 of the 5 million or so fungal species have been identified—of that number, just several hundred are known to harm humans. At the same time, changes in the environment and climate, as well as fungicide overuse in agriculture, have helped to engineer a fitter microbe—capable of infecting people and evading the few drugs designed to fight them.
SUBSCRIBER EXCLUSIVE
IN THE NEWS: WHO releases new list of fungi that pose a critical threat to human health +
PHOTOGRAPH BY JAMES CAVALLINI, SCIENCE SOURCE
COVID-19 can interfere with your period in many ways. Here’s how.
Physicians failed to warn women about the expected temporary disruptions to their periods after the vaccine, and the more significant issues after a severe bout of COVID-19.
SUBSCRIBER EXCLUSIVE
WHAT YOU SHOULD KNOW: How COVID-19 can harm pregnancy and reproductive health +
MORE HEALTH NEWS
So far, this flu season is more severe than it has been in 13 years (Washington Post)
What to know about Ozempic, TikTok’s favorite weight loss drug

A deadly monkeypox variant is surging in Central Africa. Here’s why you should be worried.
Why scientists want to create psychedelics that give better trips
How Louis Pasteur solved a medical mystery
Busting 5 common myths about water and hydration (NPR)
CORONAVIRUS UPDATE
NG STAFF
‘Obviously, that is not enough’
So far, about 22 million Americans—just seven percent of the eligible U.S. population—have received the new vaccines.
TRACKING COVID IN THE U.S.
PHOTOGRAPH BY PATRICK T. FALLON, AFP VIA GETTY IMAGES
Why Omicron subvariants BQ.1 and BQ.1.1 are poised to take over in the U.S.
They now account for a tenth of the nation’s COVID-19 cases. Here’s why these strains are so good at evading immunity—and how the vaccines will protect against them.
SUBSCRIBER EXCLUSIVE
For the masked minority, the isolation is worse than ever (Washington Post)
Americans aren’t getting the new bivalent COVID shot. What does that mean for the looming wave? (The Atlantic)
The types of COVID symptoms you get depend on the vaccines you’ve received, new data says (CNBC)
How multiple COVID-19 infections can harm the body
Omicron keeps finding new evolutionary tricks to outsmart our immunity (NPR)
Sign up here to receive our daily newsletters, covering History, Environment, Science, Animals, Travel, Photography, and Family.
SHARE YOUR THOUGHTS
We’d like to hear from you! Tell us what you think of our emails by sharing your feedback in this short survey.
TAKE THE SURVEY
SHOPDONATESUBSCRIBETRAVEL
Clicking on the Facebook, Twitter, Instagram, and National Geographic Channel links will take you away from our National Geographic Partners site where different terms of use and privacy policy apply.

This email was sent to: peter.hovis@gmail.com. Please do not reply to this email as this address is not monitored.

This email contains an advertisement from:
National Geographic | 1145 17th Street, N.W. | Washington, D.C. 20036

Stop all types of future commercial email from National Geographic regarding its products, services, or experiences.

© 2022 National Geographic Partners, LLC, All rights reserved.
Exit mobile version
Skip to toolbar